We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Strongyloidiasis Antibodies Found in Transplant Donors

By LabMedica International staff writers
Posted on 10 Dec 2018
Print article
Image: A histopathology of Strongyloides stercoralis in the duodenum (Photo courtesy of Dr. Raul S. Gonzalez, MD).
Image: A histopathology of Strongyloides stercoralis in the duodenum (Photo courtesy of Dr. Raul S. Gonzalez, MD).
Strongyloidiasis is a neglected tropical disease caused by a parasite, which is endemic in most parts of the world. It can cause a life-threatening disease among immunosuppressed individuals and can be transmitted from solid organ transplant (SOT) donors to recipients.

Due to the characteristic life cycle of Strongyloides stercoralis, individuals can carry the infection lifelong with mild or no symptoms, unless treated. The disease endemic in large parts of Latin America, Asia and Africa with an estimated prevalence of more than 400 million infected.

Scientists at the Universitat de Barcelona (Barcelona, Spain) carried out a retrospective study including all deceased individuals from endemic areas for strongyloidiasis who were considered for organ donation between January 2004 and December 2014 in the Hospital Clinic. During the period 2004–2014, 1,025 deceased individuals were evaluated as potential deceased organ donors. Of these, 90 donors (8.78%) were native from endemic areas for strongyloidiasis. Most were males (63/90 cases; 70%) and median age of all cases was 41 years old. More than half of the deceased organ donors from endemic areas had been born in Latin America (49/90 cases; 54.44%), whereas the rest were from Southeast Asia (24/90 cases; 26.67%) and Africa (17/90 cases; 18.89%).

The team used the serum samples of potential donors from endemic areas for strongyloidiasis, and performed a S. stercoralis serological test. The commercial test IVD-ELISA, which detects immunoglobulin G (IgG) antibodies by using somatic antigens from larvae of the parasite, was used and has a sensitivity of 91.2%, and a specificity of 99.1%. Currently, IVD-ELISA is the available test in the hospital. The sample is defined as positive if the absorbance/0.2 (i) > 1.1.

The scientists found there were only in 65 of 90 cases available serum samples and analyzed for S. stercoralis serology and 6/65 cases (9.23%) were found to have a positive test for strongyloidiasis. S. stercoralis serology indices ranged between 1.84 and 9.32. From the six positive cases, three individuals were native from Latin America (two from Brazil and one from Ecuador), two from Africa (Senegal and Ghana) and one from Southeast Asia (Philippines).

The authors concluded that they had found a high seroprevalence of strongyloidiasis in individuals from endemic settings evaluated as potential deceased donors for SOT. The data reinforce the importance of following current guidelines recommending systematic screening of potential donors from endemic areas. There is an urgent need to develop rapid diagnostic tests, which can be used in daily clinical practice. The study was published on November 29, 2018, in the journal Public Library of Science Neglected tropical Diseases.

Related Links:
Universitat de Barcelona

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.